Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Europe Bio Fertilizer Market

ID: MRFR/Agri/46661-HCR
128 Pages
Snehal Singh
Last Updated: April 06, 2026

Europe Bio Fertilizer Market Size, Share, Industry Trend & Analysis Research Report By Type (Nitrogen Fixing, Phosphate Solubilizing, Others), By Crop Type (Cereals & Grains, Pulses & Oilseeds, Fruits & Vegetables), By Form (Dry, Liquid), By Application (Leaf Treatment, Root Immersion, Plant Rooting, Others), By Microorganism Type (Rhizobium, Azotobacter, Azospirillum, Pseudomonas, Bacillus, VAM, Others) and By Regional (Germany, UK, France, Russia, Italy, Spain, Rest of Europe) - Forecast to 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Europe Bio Fertilizer Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Medical Device, BY Application (USD Million)
  49.     4.1.1 Soil Fertility Enhancement
  50.     4.1.2 Plant Growth Promotion
  51.     4.1.3 Disease Resistance
  52.     4.1.4 Nutrient Supply
  53.     4.1.5 Soil Health Improvement
  54.   4.2 Medical Device, BY Type (USD Million)
  55.     4.2.1 Nitrogen Fixing Bacteria
  56.     4.2.2 Phosphate Solubilizing Bacteria
  57.     4.2.3 Mycorrhizal Fungi
  58.     4.2.4 Organic Fertilizers
  59.     4.2.5 Compost
  60.   4.3 Medical Device, BY Formulation (USD Million)
  61.     4.3.1 Liquid Bio Fertilizers
  62.     4.3.2 Granular Bio Fertilizers
  63.     4.3.3 Powder Bio Fertilizers
  64.     4.3.4 Pelleted Bio Fertilizers
  65.   4.4 Medical Device, BY End Use (USD Million)
  66.     4.4.1 Cereals and Grains
  67.     4.4.2 Fruits and Vegetables
  68.     4.4.3 Pulses and Oilseeds
  69.     4.4.4 Turf and Ornamentals
  70.   4.5 Medical Device, BY Distribution Channel (USD Million)
  71.     4.5.1 Direct Sales
  72.     4.5.2 Online Sales
  73.     4.5.3 Retail Sales
  74.     4.5.4 Wholesale
  75. 5 SECTION V: COMPETITIVE ANALYSIS
  76.   5.1 Competitive Landscape
  77.     5.1.1 Overview
  78.     5.1.2 Competitive Analysis
  79.     5.1.3 Market share Analysis
  80.     5.1.4 Major Growth Strategy in the Medical Device
  81.     5.1.5 Competitive Benchmarking
  82.     5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  83.     5.1.7 Key developments and growth strategies
  84.       5.1.7.1 New Product Launch/Service Deployment
  85.       5.1.7.2 Merger & Acquisitions
  86.       5.1.7.3 Joint Ventures
  87.     5.1.8 Major Players Financial Matrix
  88.       5.1.8.1 Sales and Operating Income
  89.       5.1.8.2 Major Players R&D Expenditure. 2023
  90.   5.2 Company Profiles
  91.     5.2.1 BASF SE (DE)
  92.       5.2.1.1 Financial Overview
  93.       5.2.1.2 Products Offered
  94.       5.2.1.3 Key Developments
  95.       5.2.1.4 SWOT Analysis
  96.       5.2.1.5 Key Strategies
  97.     5.2.2 Novozymes A/S (DK)
  98.       5.2.2.1 Financial Overview
  99.       5.2.2.2 Products Offered
  100.       5.2.2.3 Key Developments
  101.       5.2.2.4 SWOT Analysis
  102.       5.2.2.5 Key Strategies
  103.     5.2.3 Syngenta AG (CH)
  104.       5.2.3.1 Financial Overview
  105.       5.2.3.2 Products Offered
  106.       5.2.3.3 Key Developments
  107.       5.2.3.4 SWOT Analysis
  108.       5.2.3.5 Key Strategies
  109.     5.2.4 Yara International ASA (NO)
  110.       5.2.4.1 Financial Overview
  111.       5.2.4.2 Products Offered
  112.       5.2.4.3 Key Developments
  113.       5.2.4.4 SWOT Analysis
  114.       5.2.4.5 Key Strategies
  115.     5.2.5 BioWorks, Inc. (US)
  116.       5.2.5.1 Financial Overview
  117.       5.2.5.2 Products Offered
  118.       5.2.5.3 Key Developments
  119.       5.2.5.4 SWOT Analysis
  120.       5.2.5.5 Key Strategies
  121.     5.2.6 AgriLife (IT)
  122.       5.2.6.1 Financial Overview
  123.       5.2.6.2 Products Offered
  124.       5.2.6.3 Key Developments
  125.       5.2.6.4 SWOT Analysis
  126.       5.2.6.5 Key Strategies
  127.     5.2.7 Rizobacter Argentina S.A. (AR)
  128.       5.2.7.1 Financial Overview
  129.       5.2.7.2 Products Offered
  130.       5.2.7.3 Key Developments
  131.       5.2.7.4 SWOT Analysis
  132.       5.2.7.5 Key Strategies
  133.     5.2.8 Koppert Biological Systems (NL)
  134.       5.2.8.1 Financial Overview
  135.       5.2.8.2 Products Offered
  136.       5.2.8.3 Key Developments
  137.       5.2.8.4 SWOT Analysis
  138.       5.2.8.5 Key Strategies
  139.     5.2.9 Biolchim S.p.A. (IT)
  140.       5.2.9.1 Financial Overview
  141.       5.2.9.2 Products Offered
  142.       5.2.9.3 Key Developments
  143.       5.2.9.4 SWOT Analysis
  144.       5.2.9.5 Key Strategies
  145.   5.3 Appendix
  146.     5.3.1 References
  147.     5.3.2 Related Reports
  148. 6 LIST OF FIGURES
  149.   6.1 MARKET SYNOPSIS
  150.   6.2 EUROPE MARKET ANALYSIS BY APPLICATION
  151.   6.3 EUROPE MARKET ANALYSIS BY TYPE
  152.   6.4 EUROPE MARKET ANALYSIS BY FORMULATION
  153.   6.5 EUROPE MARKET ANALYSIS BY END USE
  154.   6.6 EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  155.   6.7 KEY BUYING CRITERIA OF MEDICAL DEVICE
  156.   6.8 RESEARCH PROCESS OF MRFR
  157.   6.9 DRO ANALYSIS OF MEDICAL DEVICE
  158.   6.10 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
  159.   6.11 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
  160.   6.12 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
  161.   6.13 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
  162.   6.14 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
  163.   6.15 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
  164.   6.16 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
  165.   6.17 MEDICAL DEVICE, BY FORMULATION, 2024 (% SHARE)
  166.   6.18 MEDICAL DEVICE, BY FORMULATION, 2024 TO 2035 (USD Million)
  167.   6.19 MEDICAL DEVICE, BY END USE, 2024 (% SHARE)
  168.   6.20 MEDICAL DEVICE, BY END USE, 2024 TO 2035 (USD Million)
  169.   6.21 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  170.   6.22 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
  171.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  172. 7 LIST OF TABLES
  173.   7.1 LIST OF ASSUMPTIONS
  174.     7.1.1
  175.   7.2 Europe MARKET SIZE ESTIMATES; FORECAST
  176.     7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  177.     7.2.2 BY TYPE, 2026-2035 (USD Million)
  178.     7.2.3 BY FORMULATION, 2026-2035 (USD Million)
  179.     7.2.4 BY END USE, 2026-2035 (USD Million)
  180.     7.2.5 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Million)
  181.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  182.     7.3.1
  183.   7.4 ACQUISITION/PARTNERSHIP
  184.     7.4.1

Europe Medical Device Market Segmentation

Medical Device By Application (USD Million, 2026-2035)

  • Soil Fertility Enhancement
  • Plant Growth Promotion
  • Disease Resistance
  • Nutrient Supply
  • Soil Health Improvement

Medical Device By Type (USD Million, 2026-2035)

  • Nitrogen Fixing Bacteria
  • Phosphate Solubilizing Bacteria
  • Mycorrhizal Fungi
  • Organic Fertilizers
  • Compost

Medical Device By Formulation (USD Million, 2026-2035)

  • Liquid Bio Fertilizers
  • Granular Bio Fertilizers
  • Powder Bio Fertilizers
  • Pelleted Bio Fertilizers

Medical Device By End Use (USD Million, 2026-2035)

  • Cereals and Grains
  • Fruits and Vegetables
  • Pulses and Oilseeds
  • Turf and Ornamentals

Medical Device By Distribution Channel (USD Million, 2026-2035)

  • Direct Sales
  • Online Sales
  • Retail Sales
  • Wholesale

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓